Hyper Polarized Xenon-129 MRI vs Xenon-133 Scintigraphy
RecruitingPhase 1/2
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Subjects must have a diagnosis of COPD * at their clinical baseline on the day of imaging * must be clinically stable in order to participate in the study. * COPD subjects will be categorized according to the GOLD * Current/Former SmokerSubjects * must have a smoking history ≥ 10 pack years Exclusion Criteria: * Dx of asthma * Continuous oxygen use at home * Blood oxygen saturation of 92% less than as measured by pulse oximetry on the day of imaging * FEV1 percent predicted less than 25% * Pregnancy or lactation * Claustrophobia, inner ear implants, aneurysm or other surgical clips, metal foreign bodies in eye, pacemaker or other contraindication to MR scanning * Subjects with any implanted device that cannot be verified as MRI compliant will be excluded * Chest circumference greater than that of the xenon MR and/or helium coil. The circumference of the coil is approximately 42 inches * History of congenital cardiac disease, chronic renal failure, or cirrhosis * Inability to understand simple instructions or to hold still for approximately 10 seconds * History of respiratory infection within 2 weeks prior to the MR scan * History of MI, stroke and/or poorly controlled hypertension.
About the study
Hyper polarized Xenon-129 MRI will be directly compared to a radioactive Xe-133 scintigraphy to detect defects in lung ventilation from airflow limitation. This study is conducted as a pilot study with intention to conduct a larger clinical trial.
What is being tested
- Hyperpolarized Xenon-129 MRI (Experimental) (drug)
- Radioactive Xenon-133 scintigraphy (Active Comparator) (drug)
Sponsor: University of Virginia · Participants: 30 · Started: Sep 1, 2018
Contact the study team
- Sarah Struchen, RN · Phone: 4342436074
- Roselove Nunoo-Asare, RT · Phone: 4342437363
Official record on ClinicalTrials.gov — NCT03331302
Locations in the U.S.
| Virginia | University of Virginia Health System, Charlottesville |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.